Sponsored by

Anna's Daybreak News

_{Just facts, you think for yourself}

Wednesday, 5:19 AM

April 22, 2026

Good morning news friend! Discover today’s defining stories and the future they set in motion. 📰🌟

Notice: If you’re reading this email in the Gmail app, you will not be able to see both of our health articles at the bottom. 👉 Click here to view the full newsletter online — it’s free and easy to read.

Ceasefire Extension

President Trump extended the ceasefire with Iran indefinitely after Pakistan's request, despite stalled diplomatic talks and Iran refusing negotiations.

The U.S. naval blockade on Iranian ports, active since April 13, cuts $500 million daily in Iranian oil revenue; 28 vessels have been intercepted, including a sanctioned tanker. Iran calls the blockade a ceasefire violation and condemns U.S. seizures.

The conflict has caused over 5,700 deaths across Iran, Lebanon, Israel, Gulf states, and U.S. forces. Trump insists the blockade remains unless Iran submits a unified proposal.

The Strait of Hormuz stays a tense area. Oil prices surged nearly $4 to $99 a barrel amid the confrontation.

Sources: AP News, WallStreetJournal, Reuters, AXIOS, EuroNews

Fed Chair Showdown

Kevin Warsh, Trump’s nominee for Federal Reserve chair, faced Senate scrutiny over $130 million in mostly undisclosed assets, which he agreed to divest into cash and Treasury bonds.

He denied agreeing with Trump to cut interest rates, criticizing the Fed’s 2021-2022 policies as “fatal errors” causing inflation and calling for “regime change” in Fed frameworks.

Warsh cited AI-driven productivity gains to justify future rate cuts, drawing skepticism. Democrats questioned his independence, including his refusal to acknowledge Trump’s 2020 election loss.

Sen. Thomas Tillis threatens to block Warsh’s confirmation unless a Justice Department probe into Fed Chair Powell’s costly building renovation ends. Powell’s term expires May 15, 2026; Trump may fire him if he remains.

Sources: AP News, Reuters, WallStreetJournal, FinancialTimes

AI Breaches and Take Overs

Unauthorized users accessed Anthropic’s Mythos AI model at launch via a third-party contractor’s credentials, using it for benign tasks. Mythos can exploit vulnerabilities in major operating systems and browsers.

Anthropic limits access through Project Glasswing to select firms like Apple, Amazon, and Cisco and is investigating the breach with no broader impact found.

Meanwhile, SpaceX secured rights to acquire AI coding startup Cursor for $60 billion or pay $10 billion for joint projects if the deal fails. Cursor uses multiple AI models and recently launched its own.

SpaceX’s merged with xAI and plans AI satellite data centers in orbit, aiming for a $2 trillion IPO to compete with OpenAI and Anthropic by leveraging space, satellite, and supercomputing assets.

Sources: Bloomberg, Bloomberg, Reuters, WallStreetJournal

SPLC in Hot Water

The Southern Poverty Law Center faces an 11-count indictment for fraudulently funneling at least $3 million from 2014 to 2023 to extremist groups including the Ku Klux Klan and neo-Nazis via a covert informant program.

The DOJ alleges SPLC used shell companies and fake accounts to mask payments, deceiving donors and banks. Acting AG Todd Blanche accused SPLC of manufacturing extremism it claimed to oppose.

The investigation began under Biden, was revived under Trump, and led the FBI to end its SPLC partnership in 2025.

SPLC’s interim CEO denies the charges, stating they no longer use informants and will fight the case, which targets eight informants linked to extremist leaders.

Sources: WallStreetJournal, AP News, Fbi

Pancreatic Cancer Hope

Pancreatic cancer kills nearly 52,000 Americans annually, with a five-year survival rate of about 12.5%. Revolution Medicines’ drug daraxonrasib targets the RAS mutation present in over 90% of tumors.

In trials, it shrank tumors in nearly half of about 40 late-stage patients and nearly doubled survival compared to chemotherapy. BioNTech and Genentech developed a personalized mRNA vaccine for low-mutation tumors; in a 16-patient trial, half responded, and seven remain alive six years later.

The vaccine is crafted from patients’ tumor tissue within nine weeks post-surgery to stimulate immune response.

Sources: WallStreetJournal

Cannabis Pain Finding

Researchers identified four Cannabis sativa terpenes—geraniol, linalool, beta-caryophyllene, and alpha-humulene—that reduce chronic pain in mice, with geraniol being most effective.

These compounds lack THC’s psychoactive effects and act on the adenosine A2a receptor, also targeted by caffeine. Terpenes eased pain in fibromyalgia and post-surgical pain models, conditions affecting millions globally.

Opioids are current treatments but have adverse effects; terpenes could offer safer alternatives. A 2025 follow-up confirmed terpene blends reduce neuropathic pain via the same receptor.

Sources: SciTechDaily

“Don't let your honesty rot into pure gullibility. Don't let your sharp wits sour into downright swindling.”

Baked with love,

Anna Eisenberg ❤️